Can Insulet’s new diabetes data platform improve time in range and patient engagement?
Insulet launches Omnipod Discover across the US after 15,000 users adopt the platform. Examine its glucose data, clinical evidence and impact.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Insulet expands Omnipod 5 to Spain, raising the stakes in Europe’s insulin pump market
Read how Insulet’s Omnipod 5 Spain launch could reshape tubeless insulin delivery, reimbursement and connected diabetes care.
Medical Devices & Diagnostics
Insulet’s next diabetes technology challenge is not control alone, it is usability at scale
Find out how Insulet’s Omnipod 6 and fully closed-loop data could reshape automated insulin delivery for diabetes care.
Medical Devices & Diagnostics
What Insulet’s EVOLUTION 2 data means for automated insulin delivery in type 2 diabetes
Insulet's EVOLUTION 2 study shows 68% TIR with no boluses in type 2 diabetes. Analysis of what the FCL data means before the EVOLVE pivotal trial.